Persist AI Raises $12 Million in Series A Funding and Launches Cloud Lab
Persist AI secures $12 million in funding and launches Cloud Lab, enhancing drug formulation efficiency with AI and robotics. 🤖💊
Artificial intelligence approaches for anti-addiction drug discovery.
AI revolutionizes anti-addiction drug discovery, enhancing efficacy and speed in targeting complex neurochemical systems. 📈💊
New AI Tool Surpasses Other AI Models and Physicians on Medical Licensing Exam
AI tool SCAI outperforms physicians and other AI models on medical licensing exams, showing potential to enhance clinical decision-making. 🩺📊
A generative adversarial network-based accurate masked face recognition model using dual scale adaptive efficient attention network.
Innovative GAN model enhances masked face recognition accuracy using dual scale attention networks. 🤖🔍 Key for security sectors!
White Plains Hospital Collaborates with Layer Health for Enhanced Clinical Registry Reporting
White Plains Hospital partners with Layer Health to automate clinical registry reporting, improving efficiency in patient data management. 🏥🤖
A method for detection of functional deficiencies due to unilateral vestibular impairment using the TUG test and IMU sensors.
New study reveals TUG test with IMU sensors effectively detects vestibular impairments. Sensitivity up to 95%! 🧠⚖️
AI Algorithm Enhances Early Detection of Lung Cancer in General Practice
AI algorithm aids GPs in detecting lung cancer 4 months earlier, improving patient outcomes and reducing costs. 🩺💻
Gender differences in artificial intelligence: the role of artificial intelligence anxiety.
Gender impacts AI adoption: women face higher anxiety, lower positive attitudes, and usage. Study reveals significant disparities. 📊🤖
New Platform Launched by Abundant Venture Partners to Support Healthcare Startups
Abundant Venture Partners has launched a new platform to support healthcare startups, enhancing partnerships with providers. 🤝💡
Amphetamine use and Parkinson’s disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
Amphetamine may lower Parkinson's disease risk by 41% over 6 years, according to recent AI-driven research. 🧠💊